Home › Esophageal Adenocarcinoma › Colorado
Esophageal Adenocarcinoma clinical trials in Colorado
11 studies for Esophageal Adenocarcinoma are looking for participants at sites in Colorado.
Cities in Colorado
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
- Poudre Valley Hospital, Fort Collins
- and 3 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Intermountain Health Platte Valley Hospital, Brighton
- Cancer Center of Colorado at Sloan's Lake, Denver
- National Jewish Health-Main Campus, Denver
- and 11 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05677490Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Rocky Mountain Cancer Centers, LLP, Aurora
- Rocky Mountain Cancer Centers, LLP, Boulder
- Rocky Mountain Cancer Centers, LLP, Centennial
- and 11 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07392892Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- University of Colorado, Aurora
RecruitingHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Sep 15, 2026 · NCT06687603Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- University of Colorado, Aurora
Recruiting
Ages 18 to 89 · All sexes · Updated Sep 11, 2026 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Denver
- Research Site, Lone Tree
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07431281A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Denver
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07182149A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- University of Colorado - Aurora Cancer Center, Aurora
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06657144Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- University of Colorado Anschutz Medical Campus, Aurora
Recruiting
Ages 18 to 89 · All sexes · Updated Jul 1, 2026 · NCT05530343Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- UCHealth Cancer Care - Anschutz Medical Campus, Aurora
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT04900818Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
- ACUTE Center for Eating Disorders and Severe Malnutrition, Denver
- Denver Health and Hospital Authority, Denver
- Denver Health and Hospital Authority, Denver
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated Dec 10, 2025 · NCT06532734From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.